Skip to content
Advanced Therapies Congress

Advanced Therapies Congress London

Share this event

Europe’s largest cell and gene therapy conference


The Advanced Therapies Congress is taking place from 14 to 15 March 2023 at the ExCel in London.

The exhibition is welcoming 2,000 attendees, 100 exhibitors, 200 innovative young start-ups and 300 speakers from across the entire value chain of cell and gene therapy development; including forward-thinking pharma companies, researchers, clinicians, academics, HTAs, payers, and regulators.

With 8 tracks of content, the Advanced Therapies Congress agenda covers everything from manufacturing, supply chain & logistics, pricing & market access, to developments in key therapeutic areas; cell therapy, gene therapy, gene-modified cell therapy, gene editing, stem cells and regenerative medicine, and much more.


At a time of great uncertainty for biotech, and for the world itself, we gather the leaders of biotech, pharma, fast-growing industry start-ups and established solution providers to give us an expert indication of the future of cell and gene therapy.



Key Speakers

  • Peter Marks, Director, Center for Biologics Evaluation and Research (CBER), FDA
  • Peter Olagunju, CTO, TCR2
  • Jaap Boelens, Chief, Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center
  • Michael Leek, Executive Director, TC Biopharm
  • Miguel Forte, CEO, Bone Therapeutics
  • Magali Taiel, CMO, GenSight
  • Sven Kili, CEO, Antion Biosciences; Principle, Sven Kili Consulting
  • Margareth Jorvid, Head of Regulatory Affairs, Ilya Pharma AB
  • Didier Caizergues, Head of Regulatory Affairs, Genethon
  • Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
  • Lior Raviv, CTO, Pluristem therapeutics
  • Qasim Rafiq, Associate Professor in Cell and Gene Therapy Bioprocess Engineering, UCL
  • Andre Gerth, CEO, Famicord Germany
  • Moshe Israeli, Medical Director, Rabin Medical Center
  • Marcie Finney, Executive Director, Cleveland Cord Blood Center
  • Paul Carter, Director, Head Vector Processing, Quell Therapeutics
  • Greg Hopkins, Associate Manager/Scientist, Analytical Development Group, 2seventy bio
  • Mathias Svahn, CEO and Co-Founder, NextCell Pharma AB
  • Albert Ribickas, Bone Marrow Transplant Laboratory Manager, Moffitt Cancer Center
  • Joanne Kurtzberg, Professor of Paediatrics & Pathology, Duke University Medical Centre
  • Ron Jortner, Managing Director, Masthead Biosciences
  • Omar Aljitawi, Associate Professor, University of Rochester Medical Centre
  • Tara Sadeghi, EVP & Head of Operations, Cellenkos
  • Tomasz Baran, Executive VP, PBKM
  • Roger Horton, Cell and Gene Therapies Clinical Delivery Lead, Anthony Nolan
  • Jenny Prange, CSO & Head of GMP Production, MUVON Therapeutics
  • Emily McGinnis, Chief Patient Officer and Head of Government Affairs, Taysha Gene Therapies


Start-ups can attend for free

Innovative start-ups are invited to attend and exhibit the event free of charge. This offer includes:

  • A 1m booth in the start-ups zone
  • 4 full access conference passes (3 for your team, 1 for an investor)
  • Access to the networking platform with our 1800+ attendees
  • Branding and marketing materials
  • Speaking slots available 


Eligibility criteria:

  • Established 2017 onwards
  • Less than 5M GBP in funding
  • Less than 25 employees

▶️ Start-ups registration or contact

▶️  General information and registration